Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.7K
Overview
51.7K
Respiratory Regulation of Acid-Base Balance01:18

Respiratory Regulation of Acid-Base Balance

1.7K
Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2​​ and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
1.7K
What are Viruses?00:50

What are Viruses?

128.1K
Overview
128.1K
Cancer Vaccines01:30

Cancer Vaccines

1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K
Anatomy of Respiratory System II: Lower Respiratory Tract01:31

Anatomy of Respiratory System II: Lower Respiratory Tract

3.5K
The lower respiratory tract is anatomically composed of several vital structures, including the larynx, trachea, bronchial tree, alveoli, lungs, and pleurae. Each component has a specific function, and all are intricately connected to ensure efficient respiration.
The Larynx
It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
3.5K
The Respiratory System01:16

The Respiratory System

89.3K
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
89.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A subunit vaccine for multiple respiratory viruses.

Science advances·2026
Same author

Comparative study of synthetic nanofilaments assembled from amphiphilic peptides and β-peptides as antigen delivery nanostructures.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Molecular Mechanisms of Islet Amyloid Polypeptide Aggregation: Towards Chemical Strategies to Prevent Amyloid Formation and to Design Non-Aggregating Peptide Therapeutics.

International journal of molecular sciences·2026
Same author

Role of the anti-Shine-Dalgarno sequence of 16S rRNA in Flavobacterium johnsoniae.

Nucleic acids research·2026
Same author

Structure of a specialized 70S initiation complex.

Nucleic acids research·2026
Same author

Total Chemical Synthesis and Evaluation of the Antimicrobial Properties of Porcine β-Defensin 5 Against Gram-Positive and Gram-Negative Bacteria.

Probiotics and antimicrobial proteins·2026

Related Experiment Video

Updated: Jan 29, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Nanoparticle-Based Vaccines Against Respiratory Viruses.

Soultan Al-Halifa1,2, Laurie Gauthier1,2,3,4, Dominic Arpin1,2,3,4

  • 1Département de Chimie, Université du Québec à Montréal, Montreal, QC, Canada.

Frontiers in Immunology
|February 9, 2019
PubMed
Summary

Nanoparticle vaccines offer a promising solution for respiratory viruses, overcoming limitations of traditional vaccines. These advanced platforms enhance immune response, providing safe, effective, and affordable immunization against viral infections.

Keywords:
immune responsemucosal sitesnanocarriersnanovaccinerespiratory viruses

More Related Videos

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

4.1K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.3K

Related Experiment Videos

Last Updated: Jan 29, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

4.1K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.3K

Area of Science:

  • Virology
  • Immunology
  • Nanotechnology
  • Vaccinology

Background:

  • Respiratory viruses like RSV, influenza, and parainfluenza initially infect the upper respiratory tract, progressing to the lower tract and causing disease.
  • Vaccination is a key strategy for controlling viral pathogenicity and preventing pulmonary diseases.
  • Conventional vaccines (live-attenuated, inactivated, subunit) have limitations including reversion to virulence, weak immune response, and partial protection.

Purpose of the Study:

  • To review the advantages of using nanoparticles as vaccine delivery platforms against respiratory viruses.
  • To highlight examples of nanoparticle-based vaccines demonstrating potential safety, efficacy, and affordability.

Main Methods:

  • Review of current literature on nanoparticle vaccine technology.
  • Analysis of advancements in chemical and biological engineering for nanoparticle design.
  • Examination of nanoparticle characteristics influencing antigen presentation and immunogenicity.

Main Results:

  • Nanoparticles allow precise control over size, shape, functionality, and surface properties.
  • Nanoparticle vaccine platforms demonstrate enhanced antigen presentation and strong immunogenicity.
  • These platforms address limitations of conventional and subunit vaccines.

Conclusions:

  • Nanoparticles represent a new generation of vaccines with significant potential for combating respiratory viral infections.
  • Nanoparticle-based vaccines show promise as safe, effective, and affordable alternatives.
  • Further development in this area could revolutionize respiratory virus immunization strategies.